HomeNDRA • NASDAQ
ENDRA Life Sciences Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.47M | -47.16% |
Net income | -1.04M | 62.66% |
Net profit margin | — | — |
Earnings per share | -1.86 | 99.59% |
EBITDA | -1.46M | 47.36% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.06M | 81.98% |
Total assets | 3.17M | -37.35% |
Total liabilities | 1.42M | 4.05% |
Total equity | 1.75M | — |
Shares outstanding | 738.37K | — |
Price to book | 1.04 | — |
Return on assets | -96.37% | — |
Return on capital | -129.92% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.04M | 62.66% |
Cash from operations | -1.29M | 39.69% |
Cash from investing | -17.28K | 27.38% |
Cash from financing | 145.80K | -68.91% |
Net change in cash | -1.16M | 31.46% |
Free cash flow | -616.98K | 33.87% |
Previous close
$3.23
Day range
$3.23 - $3.46
Year range
$2.90 - $577.50
Market cap
2.47M USD
Avg Volume
289.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Headquarters
Website
Employees
21
